Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-label, Randomized, Controlled, Single Centre, Phase IIb Study to Assess the Immunogenicity, Reactogenicity and Safety of Three Live Oral Rotavirus Vaccines, ROTAVAC, ROTAVAC 5CM and Rotarix in Healthy Zambian Infants

Next Previous
Trial Profile

An Open-label, Randomized, Controlled, Single Centre, Phase IIb Study to Assess the Immunogenicity, Reactogenicity and Safety of Three Live Oral Rotavirus Vaccines, ROTAVAC, ROTAVAC 5CM and Rotarix in Healthy Zambian Infants

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 15 Feb 2019

At a glance

  • Drugs Bovine rotavirus vaccine reassortant (Primary) ; ORV 116E (Primary) ; RIX 4414
  • Indications Rotavirus infections
  • Focus Pharmacodynamics

    • Most Recent Events

    • 06 Feb 2019 Status changed from not yet recruiting to recruiting.
    • 02 Aug 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top